Abstract
Objectives The main objective of this study was to report stress and anxiety levels during the early period of the pandemic on early career women researchers in health sciences research and determine the factors associated with increased stress and anxiety.
Methods A 50-item self-administered internet questionnaire was developed using a mix of Likert-type scales and open-ended response questions. The survey was distributed via email and social media platforms June 10-August 3, 2020. Anxiety and stress associated with the demands of being in health sciences research as well as personal/family demands were assessed through validated measures (Patient Reported Outcomes Measurement Information System (PROMIS)-Anxiety Short Form and Perceived Stress Scale (PSS)) and open-ended responses.
Results One hundred and fifty-one early career women in healthcare sciences research completed the survey. The mean respondent age was 37.3±5.2 years, all had a college degree or higher, 50.3% holding a PhD and 35.8%, M.D. Of the 151 respondents, 128 reported their race/ethnicity and the majority were Caucasian (74.0%). One-third (31.2%) reported being ‘very much’ concerned about reaching their research productivity goals, and 30.1% were ‘very much’ concerned about academic promotion and tenure. Fifty percent reported a ‘moderate’ PROMIS anxiety score and 72.1% reported a ‘moderate’ PSS score. For the open-ended responses, 65.6% reported a worry about their professional goals as a result of the COVID-19 pandemic. Major concerns revolved around finances, childcare and job security.
Conclusions Throughout the pandemic, early career women investigators have reported high overall stress, anxiety and worries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This publication was also made possible with support from Grant Numbers, KL2TR002530 (B. Tucker Edmonds, PI), and UL1TR002529 (S. Wiehe and S. Moe, co-PIs) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Review Board (IRB) exempt study by the Indiana University IRB (IRB Protocol #2006034715).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
